We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-4.41%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
-$184M
Cap. Flow %
-2.96%
Top 10 Hldgs %
40.63%
Holding
166
New
10
Increased
38
Reduced
80
Closed
12

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$32.4M
2
UNH icon
UnitedHealth
UNH
+$23.7M
3
CI icon
Cigna
CI
+$21.4M
4
HUM icon
Humana
HUM
+$20.1M
5
APLS
Apellis Pharmaceuticals
APLS
+$12.1M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$72.3M
2
MDT icon
Medtronic
MDT
+$64.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$33M
4
CRL icon
Charles River Laboratories
CRL
+$17.5M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFY icon
151
Infosys
INFY
$46B
$19.6K ﹤0.01%
1,130
– –
UMC icon
152
United Microelectronic
UMC
$52.7B
$18.9K ﹤0.01%
2,698
– –
TSM icon
153
TSMC
TSM
$2.12T
$1.96K ﹤0.01%
1,089
– –
ASR icon
154
Grupo Aeroportuario del Sureste
ASR
$8.37B
$165 ﹤0.01%
135
– –
AMWL icon
155
American Well
AMWL
$217M
– –
-47,681
Closed -$2M
ARWR icon
156
Arrowhead Research
ARWR
$10.4B
– –
-20,700
Closed -$738K
BAX icon
157
Baxter International
BAX
$11.4B
– –
-213,434
Closed -$9.72M
DNLI icon
158
Denali Therapeutics
DNLI
$3.79B
– –
-44,050
Closed -$1.3M
FDMT icon
159
4D Molecular Therapeutics
FDMT
$575M
– –
-45,000
Closed -$813K
JMIA
160
Jumia Technologies
JMIA
$811M
– –
-18,000
Closed -$61.6K
KZR
161
DELISTED
Kezar Life Sciences
KZR
– –
-1,000
Closed -$24.5K
RCKT icon
162
Rocket Pharmaceuticals
RCKT
$382M
– –
-55,600
Closed -$1.1M
SGHT icon
163
Sight Sciences
SGHT
$275M
– –
-286,284
Closed -$2.37M
VKTX icon
164
Viking Therapeutics
VKTX
$4.35B
– –
-33,000
Closed -$535K
ABCM
165
DELISTED
Abcam PLC
ABCM
– –
-2,573
Closed -$63K
DICE
166
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-18,200
Closed -$846K
3 4 5 6
7

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q3 2023 Portfolio in Review

As of Q3 2023, Bellevue Group held 166 positions worth $6.21B, down 11% from $7.01B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellevue Group's Q3 2023 filing shows 10 new, 38 increased, 80 reduced and 12 closed positions. Its largest new stake was Viatris: 176,848 shares worth $1.74M. The largest sale was Inspire Medical Systems, an estimated $72.3M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Industrials and Energy.

  • Bellevue Group's largest Q3 2023 buy was Viatris: 176,848 shares worth $1.74M.
  • Bellevue Group added most to Elevance Health in Q3 2023, an estimated $32.4M increase.
  • Bellevue Group's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $72.3M.
  • Bellevue Group fully exited Baxter International in Q3 2023, selling an estimated $9.72M.
  • Bellevue Group's ten largest holdings make up 41% of its $6.21B portfolio in Q3 2023.
  • Bellevue Group opened 10 new positions and closed 12 in Q3 2023.
  • Bellevue Group's portfolio value fell 11% quarter-over-quarter to $6.21B.

Based on Bellevue Group's 13F filing for Q3 2023, filed 14 Nov 2023.